메뉴 건너뛰기
European Journal of Oncology Nursing
Volumn 11, Issue SUPPL. 2, 2007, Pages
Role of the nurse in preserving patients' independence
Author keywords

Autonomy; Bisphosphonates; Metastatic bone disease; Patient education; Patient management; Quality of life; Zoledronic acid
Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE; ZOLEDRONIC ACID;
EID: 34548637483     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2007.07.004     Document Type: Article
Times cited : (5)
References (8)
  • 1
    • 0035010803 scopus 로고    scopus 로고
    • Metastatic bone disease: clinical features, pathophysiology and treatment strategies
    • Coleman R.E. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treatment Reviews 27 (2001) 165-176
    • (2001) Cancer Treatment Reviews , vol.27 , pp. 165-176
    • Coleman, R.E.1
  • 2
    • 33750726077 scopus 로고    scopus 로고
    • Clinical features of metastatic bone disease and risk of skeletal morbidity
    • Coleman R.E. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clinical Cancer Research 12 (2006) 6243s-6249s
    • (2006) Clinical Cancer Research , vol.12
    • Coleman, R.E.1
  • 3
    • 33947429732 scopus 로고    scopus 로고
    • Medication persistence with weekly versus daily doses of orally administered bisphosphonates
    • Ettinger M.P., Gallagher R., and MacCosbe P.E. Medication persistence with weekly versus daily doses of orally administered bisphosphonates. Endocrine Practice 12 (2006) 522-528
    • (2006) Endocrine Practice , vol.12 , pp. 522-528
    • Ettinger, M.P.1    Gallagher, R.2    MacCosbe, P.E.3
  • 4
    • 33846448782 scopus 로고    scopus 로고
    • The use of bisphosphonates in elderly cancer patients
    • Gridelli C. The use of bisphosphonates in elderly cancer patients. The Oncologist 12 (2007) 62-71
    • (2007) The Oncologist , vol.12 , pp. 62-71
    • Gridelli, C.1
  • 5
    • 33748929053 scopus 로고    scopus 로고
    • Rates and determinants of patients persistency with oral bisphosphonates in cancer patients
    • [abstract 07-057]
    • Hoer A., Gol D., Gothe H., Schiffhorst G., Brandman J., and Haussler B. Rates and determinants of patients persistency with oral bisphosphonates in cancer patients. Supportive Care in Cancer 13 (2005) 428 [abstract 07-057]
    • (2005) Supportive Care in Cancer , vol.13 , pp. 428
    • Hoer, A.1    Gol, D.2    Gothe, H.3    Schiffhorst, G.4    Brandman, J.5    Haussler, B.6
  • 6
    • 10744233021 scopus 로고    scopus 로고
    • Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial
    • Rosen L.S., Gordon D., Kaminski M., Howell A., Belch A., Mackey J., Apffelstaedt J., Hussein M.A., Coleman R.E., Reitsma D.J., Chen B.-L., and Seaman J.J. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer 98 (2003) 1735-1744
    • (2003) Cancer , vol.98 , pp. 1735-1744
    • Rosen, L.S.1    Gordon, D.2    Kaminski, M.3    Howell, A.4    Belch, A.5    Mackey, J.6    Apffelstaedt, J.7    Hussein, M.A.8    Coleman, R.E.9    Reitsma, D.J.10    Chen, B.-L.11    Seaman, J.J.12
  • 7
    • 33746821808 scopus 로고    scopus 로고
    • Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases
    • Siris E.S., Harris S.T., Rosen C.J., Barr C.E., Arvesen J.N., Abbott T.A., and Silverman S. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clinic Proceedings 81 (2006) 1013-1022
    • (2006) Mayo Clinic Proceedings , vol.81 , pp. 1013-1022
    • Siris, E.S.1    Harris, S.T.2    Rosen, C.J.3    Barr, C.E.4    Arvesen, J.N.5    Abbott, T.A.6    Silverman, S.7
  • 8
    • 33646863929 scopus 로고    scopus 로고
    • Management of the adverse effects associated with intravenous bisphosphonates
    • Tanvetyanon T., and Stiff P.J. Management of the adverse effects associated with intravenous bisphosphonates. Annals of Oncology 17 (2006) 897-907
    • (2006) Annals of Oncology , vol.17 , pp. 897-907
    • Tanvetyanon, T.1    Stiff, P.J.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.